495 related articles for article (PubMed ID: 27368089)
1. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression.
Hirschberg C; Sun CC; Rantanen J
J Pharm Biomed Anal; 2016 Sep; 128():462-468. PubMed ID: 27368089
[TBL] [Abstract][Full Text] [Related]
2. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
Sun WJ; Aburub A; Sun CC
J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940
[TBL] [Abstract][Full Text] [Related]
3. Systematic development of a high dosage formulation to enable direct compression of a poorly flowing API: A case study.
Schaller BE; Moroney KM; Castro-Dominguez B; Cronin P; Belen-Girona J; Ruane P; Croker DM; Walker GM
Int J Pharm; 2019 Jul; 566():615-630. PubMed ID: 31158454
[TBL] [Abstract][Full Text] [Related]
4. Insight Into a Novel Strategy for the Design of Tablet Formulations Intended for Direct Compression.
Capece M; Huang Z; Davé R
J Pharm Sci; 2017 Jun; 106(6):1608-1617. PubMed ID: 28283431
[TBL] [Abstract][Full Text] [Related]
5. Enabling tablet product development of 5-fluorocytosine through integrated crystal and particle engineering.
Perumalla SR; Sun CC
J Pharm Sci; 2014 Apr; 103(4):1126-32. PubMed ID: 24515970
[TBL] [Abstract][Full Text] [Related]
6. Crystal coating via spray drying to improve powder tabletability.
Vanhoorne V; Peeters E; Van Snick B; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2014 Nov; 88(3):939-44. PubMed ID: 25445306
[TBL] [Abstract][Full Text] [Related]
7. A microcrystalline cellulose based drug-composite formulation strategy for developing low dose drug tablets.
Sun WJ; Sun CC
Int J Pharm; 2020 Jul; 585():119517. PubMed ID: 32526333
[TBL] [Abstract][Full Text] [Related]
8. The influence of direct compression powder blend transfer method from the container to the tablet press on product critical quality attributes: a case study.
Teżyk M; Jakubowska E; Milczewska K; Milanowski B; Voelkel A; Lulek J
Drug Dev Ind Pharm; 2017 Jun; 43(6):911-916. PubMed ID: 28032521
[TBL] [Abstract][Full Text] [Related]
9. Systematic study of paracetamol powder mixtures and granules tabletability: Key role of rheological properties and dynamic image analysis.
Macho O; Gabrišová Ľ; Brokešová J; Svačinová P; Mužíková J; Galbavá P; Blaško J; Šklubalová Z
Int J Pharm; 2021 Oct; 608():121110. PubMed ID: 34547394
[TBL] [Abstract][Full Text] [Related]
10. Utility of Microcrystalline Cellulose for Improving Drug Content Uniformity in Tablet Manufacturing Using Direct Powder Compression.
Nakamura S; Tanaka C; Yuasa H; Sakamoto T
AAPS PharmSciTech; 2019 Mar; 20(4):151. PubMed ID: 30903317
[TBL] [Abstract][Full Text] [Related]
11. Improving the Manufacturability of Cohesive and Poorly Compactable API for Direct Compression of Mini-tablets at High Drug Loading via Particle Engineering.
Chen L; Lin Y; Irdam E; Madden N; Osei-Yeboah F
Pharm Res; 2022 Dec; 39(12):3185-3195. PubMed ID: 36319885
[TBL] [Abstract][Full Text] [Related]
12. A novel mixing rule model to predict the flowability of directly compressed pharmaceutical blends.
Aroniada M; Bano G; Vueva Y; Christodoulou C; Li F; Litster JD
Int J Pharm; 2023 Nov; 647():123475. PubMed ID: 37832706
[TBL] [Abstract][Full Text] [Related]
13. Massing in high shear wet granulation can simultaneously improve powder flow and deteriorate powder compaction: a double-edged sword.
Shi L; Feng Y; Sun CC
Eur J Pharm Sci; 2011 May; 43(1-2):50-6. PubMed ID: 21443948
[TBL] [Abstract][Full Text] [Related]
14. A compression behavior classification system of pharmaceutical powders for accelerating direct compression tablet formulation design.
Dai S; Xu B; Zhang Z; Yu J; Wang F; Shi X; Qiao Y
Int J Pharm; 2019 Dec; 572():118742. PubMed ID: 31648016
[TBL] [Abstract][Full Text] [Related]
15. Direct Compression Tablet Containing 99% Active Ingredient-A Tale of Spherical Crystallization.
Chen H; Aburub A; Sun CC
J Pharm Sci; 2019 Apr; 108(4):1396-1400. PubMed ID: 30448523
[TBL] [Abstract][Full Text] [Related]
16. Modulating Sticking Propensity of Pharmaceuticals Through Excipient Selection in a Direct Compression Tablet Formulation.
Paul S; Sun CC
Pharm Res; 2018 Mar; 35(6):113. PubMed ID: 29603027
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and prediction of powder flowability in pharmaceutical tableting.
Hildebrandt C; Gopireddy SR; Fritsch AK; Profitlich T; Scherließ R; Urbanetz NA
Pharm Dev Technol; 2019 Jan; 24(1):35-47. PubMed ID: 29227171
[TBL] [Abstract][Full Text] [Related]
18. Trace polymer coated clarithromycin spherulites: Formation mechanism, improvement in pharmaceutical properties and development of high-drug-loading direct compression tablets.
Zhang X; Su M; Meng W; Zhao J; Huang M; Zhang J; Qian S; Gao Y; Wei Y
Int J Pharm; 2024 Apr; 654():123944. PubMed ID: 38403089
[TBL] [Abstract][Full Text] [Related]
19. Engineered particles demonstrate improved flow properties at elevated drug loadings for direct compression manufacturing.
Trementozzi AN; Leung CY; Osei-Yeboah F; Irdam E; Lin Y; MacPhee JM; Boulas P; Karki SB; Zawaneh PN
Int J Pharm; 2017 May; 523(1):133-141. PubMed ID: 28284921
[TBL] [Abstract][Full Text] [Related]
20. Roller compaction of moist pharmaceutical powders.
Wu CY; Hung WL; Miguélez-Morán AM; Gururajan B; Seville JP
Int J Pharm; 2010 May; 391(1-2):90-7. PubMed ID: 20176096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
